(Q33738009)

29 July 2017

1 reference

title

Growth hormone therapy for heart failure: swimming against the stream (English)

1 reference

29 July 2017

Saccà L

1

1 reference

29 July 2017

1 September 1999

1 reference

Journal of Cardiac Failure

29 July 2017

1 reference

29 July 2017

5

1 reference

29 July 2017

3

1 reference

29 July 2017

269-275

1 reference

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Quantitative structural analysis of the myocardium during physiologic growth and induced cardiac hypertrophy: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Structural remodeling and mechanical dysfunction of cardiac myocytes in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Cellular basis of chronic ventricular remodeling after myocardial infarction in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Structural basis of end-stage failure in ischemic cardiomyopathy in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Cytoskeletal role in the transition from compensated to decompensated hypertrophy during adult canine left ventricular pressure overloading

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Heterogeneous immediate effects of partial left ventriculectomy on cardiac performance

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Angiotensin-converting enzyme inhibition and beta-adrenoceptor blockade regress established ventricular remodeling in a canine model of discrete myocardial damage

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Effect of angiotensin-converting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium from the spontaneously hypertensive rat

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Changes in left ventricular mass and volumes in patients receiving angiotensin-converting enzyme inhibitor therapy for left ventricular dysfunction after Q-wave myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Lack of reflex increase in myocardial sympathetic tone after captopril: potential antianginal effect

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Cardiac myocyte necrosis induced by angiotensin II

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Regression of cellular hypertrophy after left ventricular assist device support

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Left ventricular echocardiographic and histologic changes: impact of chronic unloading by an implantable ventricular assist device

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Growth hormone and the heart

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Cardiac performance: growth hormone enters the race

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Growth hormone: a newcomer in cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Insulin-like Growth Factor-I Rapidly Activates Multiple Signal Transduction Pathways in Cultured Rat Cardiac Myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Improvement of doxorubicin induced cardiomyopathy in rats treated with insulin-like growth factor I

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Growth Hormone Improves Cardiac Performance in Experimental Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Beneficial effects of growth hormone and insulin-like growth factor-1 in experimental heart failure in rats treated with chronic ACE inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Differential effects of growth hormone on cardiomyocyte and extracellular matrix protein remodeling following experimental myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Apoptosis in myocytes in end-stage heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

A Preliminary Study of Growth Hormone in the Treatment of Dilated Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Exogenously administered growth hormone and insulin-like growth factor-I alter intracellular Ca2+ handling and enhance cardiac performance. In vitro evaluation in the isolated isovolumic buffer-perfused rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

A placebo-controlled study of growth hormone in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Effects of constitutive overexpression of insulin-like growth factor-1 on the mechanical characteristics and molecular properties of ventricular myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Mechanical properties of rat cardiac skinned fibers are altered by chronic growth hormone hypersecretion.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Treatment With Growth Hormone Enhances Contractile Reserve and Intracellular Calcium Transients in Myocytes From Rats With Postinfarction Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Growth hormone preserves cardiac sarcoplasmic reticulum Ca2+ release channels (ryanodine receptors) and enhances cardiac function in cardiomyopathic hamsters

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Sympathetic deactivation by growth hormone treatment in patients with dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

Intense sympathetic nerve activity in adults with hypopituitarism and untreated growth hormone deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990012-X

7 January 2021

10.1016/S1071-9164(99)90012-X

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10496200